Clearing airways and improving outcomes with HFCWO

Along with antibiotics and other medications, you’ll find that airway clearance therapies such as high frequency chest wall oscillation (HFCWO), or “vest therapy,” provide an effective, safe treatment for patients with bronchiectasis—treatment that can help your patients enjoy a better quality of life and prevent further lung damage.

Hillrom patient wearing Monarch vest playing guitar

How does HFCWO work?

  • An HFCWO vest rapidly oscillates against the chest, gently compressing and releasing the chest wall to create increased airflow within the lungs
  • This process thins and moves mucus toward the larger airways where it can be cleared by coughing or suction
  • Reducing mucus build up in the lungs helps reduce the frequency of infection and hospitalizations while also helping prevent further lung damage
  • HFCWO therapy does not require special skills—most patients are able to perform it on their own


HFCWO therapy gets results

HFCWO therapy has been shown to significantly improve outcomes for patients with bronchiectasis. That includes reducing the rate of hospitalization by 65%1, keeping more of your patients at home and out of the hospital.

Improving patients’ outcomes with HFCWO therapy1

HFCWO and BE Clinical Research Summary (PDF)HFCWO Basavaraj Study Summary Sheet

Get an in-depth look at HFCWO’s improved outcomes

Download this study to learn more about what HFCWO has to offer your patients, including reduced hospitalizations and ER visits. You’ll also get a look at the type of patients who benefit most from HFCWO.

Effectiveness of Treatment with HFCWO (PDF)“Effectiveness of Treatment with HFCWO” Data Sheet PDF

More data, more improvements

See how HFCWO helped patients with bronchiectasis show significant improvement in dyspnea and QOL—plus improvements in respiratory function compared to PEP/CPT.

  1. Basavaraj, M. DeKoven, D. Shah, et al. Impact of High Frequency Chest Wall Oscillation on Clinical Outcomes and Healthcare Resource Utilization in Adult Patients with Non-Cystic Fibrosis Bronchiectasis in the United States: A Pre-Post Cohort Analysis. American Journal of Respiratory and Critical Care Medicine 2020;201:A7758.

©2020 Hill-Rom Services PTE Ltd. ALL RIGHTS RESERVED.
APR130701 rev 1    29-SEP-2020               ENG – US